X
MRVI icon

Xponance’s Maravai LifeSciences MRVI Stock Holding History

Xponance’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,297
Closed -$89.3K – 1349
2024
Q1 		$89.3K Sell
10,297
-706
-6% -$4.78K ﹤0.01% 1246
2023
Q4 		$72.1K Buy
11,003
+391
+4% +$2.53K ﹤0.01% 1223
2023
Q3 		$106K Buy
10,612
+88
+0.8% +$966 ﹤0.01% 1163
2023
Q2 		$131K Sell
10,524
-5,009
-32% -$67.6K ﹤0.01% 1178
2023
Q1 		$218K Buy
15,533
+1,070
+7% +$15.4K ﹤0.01% 1109
2022
Q4 		$207K Buy
14,463
+1,435
+11% +$22.6K ﹤0.01% 1116
2022
Q3 		$333K Buy
13,028
+190
+1% +$4.77K 0.01% 966
2022
Q2 		$365K Buy
12,838
+641
+5% +$20.3K 0.01% 960
2022
Q1 		$430K Sell
12,197
-540
-4% -$18.1K 0.01% 945
2021
Q4 		$534K Buy
12,737
+1,207
+10% +$48.9K 0.01% 875
2021
Q3 		$566K Buy
11,530
+2,922
+34% +$143K 0.01% 832
2021
Q2 		$359K Buy
+8,608
New +$334K 0.01% 1026

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Xponance's MRVI Position: Q2 2024 in Review

Xponance sold out of Maravai LifeSciences (MRVI) in Q2 2024, closing a stake of 10,297 shares — an estimated $89.3K sold.

Xponance first reported a position in MRVI in Q2 2021 and held it in 12 quarters. The position peaked at $566K in Q3 2021. 206 funds tracked by Wall St. Rank hold MRVI as of Q2 2024.

  • Xponance reported no remaining Maravai LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Xponance sold 10,297 Maravai LifeSciences shares in Q2 2024, an estimated $89.3K.
  • Xponance first reported a position in Maravai LifeSciences in Q2 2021 and held it in 12 quarters.
  • Xponance's Maravai LifeSciences position peaked at $566K in Q3 2021.
  • 206 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2024.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.